Skip to content

CTMED: what changed

BE 0716.964.216NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€540,580
2024 · €536,520+€4,060
Equity
€905,403
2024 · €905,403
Cash
€888,660
2024 · €272,902+€615,759
Balance sheet total
€1.9m
2024 · €1.5m+€464,845

Largest movements

2024 to 2025
Assets
  • Cash +€615,759

    up €615,759 (+226%), from €272,902 to €888,660

    mainly Net result for the year (+€540,580) and Other debts (+€459,435)

  • Current investments -€128,678

    down €128,678 (-15.0%), from €860,700 to €732,021

  • Deferred charges and accrued income +€54,051

    up €54,051 (+637%), from €8,479 to €62,529

  • Intangible fixed assets -€40,000

    down €40,000 (-25.0%), from €160,000 to €120,000

  • Receivables within one year -€25,395

    down €25,395 (-59.7%), from €42,559 to €17,164

    of which Trade receivables: -€19,655

Equity and liabilities
  • Other debts +€459,435

    up €459,435 (+81.5%), from €564,005 to €1.0m

Income statement
  • Gross operating margin +€22,793

    up €22,793 (+2.9%), from €784,428 to €807,221

  • Other operating charges +€9,070

    up €9,070 (+479%), from €1,892 to €10,962

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €536,520
Gross operating margin +€22,793
Staff costs -€1,317
Depreciation -€275
Other operating charges -€9,070
Financial income -€2,848
Financial charges -€925
Taxes -€4,299
Result 2025 €540,580
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€1.0m
Investment +€113,173
Financing -€540,580
Cash 2024 €272,902
Net result for the year +€540,580
Depreciation +€66,397
Receivables within one year +€25,395
Deferred charges and accrued income -€54,051
Trade debts +€5,570
Smaller working-capital items -€159
Other debts +€459,435
Investment in fixed assets (net) -€15,506
Current investments +€128,678
Contributions, distributions and other -€540,580
Cash 2025 €888,660
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,474,786 €1,939,631 +€464,845 +31.5%
Fixed assets 21/28 €290,147 €239,256 -€50,891 -17.5%
Intangible fixed assets 21 €160,000 €120,000 -€40,000 -25.0%
Tangible fixed assets 22/27 €130,060 €119,169 -€10,891 -8.4%
Plant, machinery and equipment 23 €805 €402 -€403 -50.1%
Furniture and vehicles 24 €9,522 €15,455 +€5,932 +62.3%
Other tangible fixed assets 26 €119,733 €103,313 -€16,420 -13.7%
Financial fixed assets 28 €87 €87 = 0.0%
Current assets 29/58 €1,184,639 €1,700,375 +€515,737 +43.5%
Amounts receivable within one year 40/41 €42,559 €17,164 -€25,395 -59.7%
Trade receivables 40 €30,584 €10,929 -€19,655 -64.3%
Other amounts receivable 41 €11,975 €6,235 -€5,739 -47.9%
Current investments 50/53 €860,700 €732,021 -€128,678 -15.0%
Cash at bank and in hand 54/58 €272,902 €888,660 +€615,759 +226%
Deferred charges and accrued income 490/1 €8,479 €62,529 +€54,051 +637%
Total equity and liabilities 10/49 €1,474,786 €1,939,631 +€464,845 +31.5%
Equity 10/15 €905,403 €905,403 = 0.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €886,803 €886,803 = 0.0%
Distributable reserves 133 €886,803 €886,803 = 0.0%
Amounts payable 17/49 €569,382 €1,034,228 +€464,845 +81.6%
Amounts payable within one year 42/48 €568,964 €1,034,228 +€465,263 +81.8%
Trade debts 44 - €5,570 +€5,570
Suppliers 440/4 - €5,570 +€5,570
Taxes, remuneration and social security 45 €4,959 €5,218 +€259 +5.2%
Remuneration and social security 454/9 €4,959 €5,218 +€259 +5.2%
Other amounts payable 47/48 €564,005 €1,023,440 +€459,435 +81.5%
Accrued charges and deferred income 492/3 €418 - -€418
Remuneration, social security and pensions 62 €22,758 €24,075 +€1,317 +5.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €66,123 €66,397 +€275 +0.4%
Other operating charges 640/8 €1,892 €10,962 +€9,070 +479%
Gross operating margin 9900 €784,428 €807,221 +€22,793 +2.9%
Operating profit (loss) 9901 €693,655 €705,787 +€12,132 +1.7%
Financial income 75/76B €21,525 €18,677 -€2,848 -13.2%
Recurring financial income 75 €21,525 €18,677 -€2,848 -13.2%
Financial charges 65/66B €5,704 €6,629 +€925 +16.2%
Recurring financial charges 65 €5,704 €6,629 +€925 +16.2%
Profit (loss) for the period before taxes 9903 €709,476 €717,835 +€8,359 +1.2%
Income taxes 67/77 €172,957 €177,255 +€4,299 +2.5%
Profit (loss) for the period 9904 €536,520 €540,580 +€4,060 +0.8%
Profit (loss) for the period to be appropriated 9905 €536,520 €540,580 +€4,060 +0.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€2.2m to €3.0m

Midpoint €2.5m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €785,403
Capitalised earnings €3.7m to €5.2m
Indication €2.2m to €3.0m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€905,403
Intangible fixed assets (21)
-€120,000
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€785,403

Capitalised earnings

net result for the year (9904)
2025
€540,580
2024
€536,520
2023
€469,254
2022
€441,041
2021
€392,778
Average result
€515,451
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€3.7m / €4.3m / €5.2m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.